Sanofi Engages In Exclusive Talks With US Private Equity CD&R For Its Consumer...

Published on 21 Oct 2024 on Benzinga · via AOL

Sanofi SA (NASDAQ:SNY) and private equity Clayton Dubilier & Rice (CD&R) have finally entered into...

Read the rest of the article

Start tracking your investments with Statfolio

In his iconic song The Gambler, Kenny Rogers famously sang, “Every hand’s a winner, and every han...

TipRanks · via Yahoo Finance 29 Oct 2024

Regeneron last year won approval for a higher-dose version of its star eye disease drug Eylea -- ...

The Motley Fool · via AOL 28 Oct 2024

Welcome to the Q3 2024 conference call for investors and analysts. As usual, you can find the sli...

The Motley Fool · via AOL 25 Oct 2024

The results show that Ebglyss improved skin (including hand and face) and itch among patients wit...

Benzinga · via Yahoo Finance 25 Oct 2024

French drug maker Sanofi on Friday posted stronger earnings growth than analysts had expected in ...

Reuters · via Yahoo Finance 25 Oct 2024

On Friday, Sanofi SA (NASDAQ:SNY) reported a third-quarter business operating income of 4.61 bill...

Benzinga · via AOL 25 Oct 2024

According to FactSet, the company posted profit of $1.54 per share on $14.51 billion in sales. Sa...

Investor's Business Daily 25 Oct 2024

The company’s performance beat Wall Street expectations, pushing its share price higher in Friday...

BioPharma Dive · via Yahoo Finance 25 Oct 2024

On Friday, Sanofi SA (NASDAQ:SNY) reported a third-quarter business operating income of 4.61 bill...

Benzinga · via Yahoo Finance 25 Oct 2024

French drug maker Sanofi on Friday posted stronger earnings growth than analysts had expected in ...

Reuters · via Yahoo Finance 25 Oct 2024